Alnylam Pharmaceuticals, Inc.
News
Are Investors Undervaluing Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) By 49%?
Simply Wall St Key Insights Using the 2 Stage Free Cash Flow to Equity, Alnylam Pharmaceuticals fair value estimate is US$512 Alnylam...\n more…
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Acquired by Acadian Asset Management LLC
Zolmax Acadian Asset Management LLC boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 2,148.9% in the second quarter, according to its most recent filing with the...\n more…
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Purchased by Acadian Asset Management LLC
Ticker Report Acadian Asset Management LLC raised its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 2,148.9% during the second quarter, according to the company in its most recent...\n more…
Allspring Global Investments Holdings LLC Grows Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Ticker Report Allspring Global Investments Holdings LLC increased its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 54.2% during the 2nd quarter, Holdings Channel reports. The...\n more…
Cantor Fitzgerald Reaffirms Neutral Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)
Ticker Report Cantor Fitzgerald reaffirmed their neutral rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY - Free Report) in a research note published on Monday, Benzinga reports. They currently have a...\n more…
Emerald Advisers LLC Has $393,000 Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Zolmax Emerald Advisers LLC reduced its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 21.8% in the 2nd quarter, according to the company in its most recent disclosure with the...\n more…